Navigation Links
MedAvante Central Ratings Selected For Cerecor Investigational MDD Study
Date:12/2/2013

assessments in place of different raters at every site, we can minimize variability of study data and avoid perception biases which can increase placebo response and reduce observed drug effect," he said.  "We are proud to bring these capabilities to the Cerecor study."

About MedAvante, Inc.

MedAvante is the leading global provider of centralized expert psychiatric and neurocognition rating and monitoring services to the pharmaceutical, biotechnology and medical device industries.  MedAvante central trial services help sponsors enhance assay sensitivity for increased drug effect and reduced trial failure rates, enabling them to bring better drugs to market faster. Supported by operational teams in the US, Germany, Russia and Japan, MedAvante clinicians located in 31 countries and speaking 26 languages deliver Central Trial Services in 41 countries worldwide.
For more information, please visit www.medavante.com.

About Cerecor Inc.

Cerecor Inc. is a privately held clinical stage biopharmaceutical company developing prescription pharmaceuticals that work in the human nervous system and which address the needs of underserved patient segments of major diseases.  We are committed to the development of drugs that improve lives by applying our extensive knowledge and experience in central nervous system disorders.  www.cerecor.com


'/>"/>
SOURCE MedAvante, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Breaking Study: ICU Medicals Tego® Needlefree Connector Proves More Cost Effective Than Traditional Central Venous Catheter Locks
2. A molecule central to diabetes is uncovered
3. Debiopharm Announces First Patient Enrolled in Phase III Study for the Rare Disease Central Precocious Puberty
4. Florida-Based Team Gemini Signs Recycling Facility Agreement with Solid Waste Authority of Central Ohio
5. BioHealth Innovation, Inc. Forms Commercial Relevance Advisory Board to Help Advance Market-Relevant Innovations in Central Maryland
6. ‘Timely’ new undergrad program in photonics at University of Central Florida applauded by SPIE
7. Site Quality Management to Optimize Risk-Based and Centralized Monitoring, New Life Science Webinar Hosted by Xtalks
8. Central Nervous System (CNS) Biomarkers Market: 2017 Forecast in New Research Report at ReportsnReports.com
9. Endpoint Based Protocol Development: A Central Laboratory Perspective + Microbiology Case Study, New Life Science Webinar Hosted by Xtalks
10. Congresso ESH 2013, dallo studio SEVITENSION nuove evidenze sullefficacia della combinazione fissa olmesartan/amlodipina vs. perindopril/amlodipina nel controllo della pressione arteriosa centrale
11. ResearchMoz.us: Private Healthcare Market - Investigation, Study, Size, Share in Central Europe and Poland and Poland 2013
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/31/2014)... 31, 2014 CollabRx, Inc. (NASDAQ: CLRX), ... decision-making in oncology, today announced that it will hold ... discuss the Company's financial results for the first quarter ... the business in the current fiscal year. , The ... Thursday, August 14, 2014, at 5 p.m. EDT (2 ...
(Date:7/31/2014)... 2014  Smith & Nephew (LSE:SN, NYSE: ... today announced its entry into the forefoot market ... Repair System. Comprised of three separate repair options, ... ligament repair and reconstruction, a metatarsal osteotomy guide, ... (PIP) fusion, also known as hammer toe correction. ...
(Date:7/31/2014)... Held at the Stanford Cancer Center, ... of the disease and its treatment. Survivors will find ... well as updates on the state-of-the-art with respect to ... for organizing this educational opportunity,” says KCA CEO Bill ... her colleagues have put together a program that balances ...
(Date:7/31/2014)... The global market for molecular diagnostics ... according to a new study by Grand View Research, ... the subsequent introduction of advanced cancer diagnostic technologies are ... the next six years. Moreover, the growing global base ... coupled with disease triggering lifestyle habits such as smoking ...
Breaking Biology Technology:CollabRx, Inc. Schedules First Quarter Fiscal Year 2015 Financial Conference Call and Business Update 2Smith & Nephew scores a HAT-TRICK with its entry into the high-growth hammer toe repair market 2Smith & Nephew scores a HAT-TRICK with its entry into the high-growth hammer toe repair market 3Smith & Nephew scores a HAT-TRICK with its entry into the high-growth hammer toe repair market 4Molecular Diagnostics Market - Global Industry Size, Share, Trends, Analysis, Players, Opportunity, Outlook and Forecast From 2014 to 2020 2Molecular Diagnostics Market - Global Industry Size, Share, Trends, Analysis, Players, Opportunity, Outlook and Forecast From 2014 to 2020 3Molecular Diagnostics Market - Global Industry Size, Share, Trends, Analysis, Players, Opportunity, Outlook and Forecast From 2014 to 2020 4Molecular Diagnostics Market - Global Industry Size, Share, Trends, Analysis, Players, Opportunity, Outlook and Forecast From 2014 to 2020 5
... potentially reach $1 billion by 2014SEATTLE, March 19 ... and MTA: CTIC) reviewed CTI,s programs in a presentation ... Wednesday, March 18th . Mr. Philips, highlights focused ... non-Hodgkin,s lymphoma (NHL) and OPAXIO for treatment of non-small ...
... (Nasdaq: MEDX ) announced today that it is ... Today & Tomorrow Conference at 11:20 a.m. Eastern Time on ... and will be available in the Investor Relations section of ... of the presentation will be available following the event. About ...
... InterMune, Inc. (Nasdaq: ITMN ) today announced ... (R7227) and the company,s research programs related to the hepatitis ... 44th Annual Meeting of the European Association for the Study ... The abstracts are expected to be available at ...
Cached Biology Technology:Cell Therapeutics Presents Corporate Highlights at Invest Northwest Conference 2Cell Therapeutics Presents Corporate Highlights at Invest Northwest Conference 3InterMune to Present Abstracts on HCV Protease Inhibitor ITMN-191 and HCV Development Program at the EASL Meeting 2InterMune to Present Abstracts on HCV Protease Inhibitor ITMN-191 and HCV Development Program at the EASL Meeting 3
(Date:7/30/2014)... reversible epigenetic processes to regulate its genes, and adapt ... picture of the genome regulation taking place in the ... Genome Biology and illustrates how the truffle deals ... The authors say this may shed light on how ... truffles (Tuber melanosporum), also known as Prigord truffles, have ...
(Date:7/30/2014)... American Chemical Society (ACS) announced today that David L. ... ACS Biomaterials Science & Engineering as editor-in-chief. With ... the new journal will feature high-quality research in the ... or naturally derived materials that interact with living or ... it reflects the tremendous growth in the field of ...
(Date:7/30/2014)... of the Entomological Society of America (ESA) has elected ... election as a Fellow acknowledges outstanding contributions to entomology ... extension, or administration. The following Fellows will be recognized ... which will be held November 16-19, 2014 in Portland, ... a professor with the Department of Plant, Soil and ...
Breaking Biology News(10 mins):How black truffles deal with the jumpers in their genome 2ACS Biomaterials Science & Engineering: Brand-new journal launches in 2015, names editor 2Entomological Society of America recognizes 2014 fellows 2Entomological Society of America recognizes 2014 fellows 3Entomological Society of America recognizes 2014 fellows 4Entomological Society of America recognizes 2014 fellows 5Entomological Society of America recognizes 2014 fellows 6Entomological Society of America recognizes 2014 fellows 7Entomological Society of America recognizes 2014 fellows 8Entomological Society of America recognizes 2014 fellows 9Entomological Society of America recognizes 2014 fellows 10Entomological Society of America recognizes 2014 fellows 11Entomological Society of America recognizes 2014 fellows 12Entomological Society of America recognizes 2014 fellows 13Entomological Society of America recognizes 2014 fellows 14Entomological Society of America recognizes 2014 fellows 15Entomological Society of America recognizes 2014 fellows 16Entomological Society of America recognizes 2014 fellows 17
... antibodies for use in vaccines and cancer medicines, enzymes ... substances can already be produced on a large scale ... met by making use of living cells or organisms. ... the target protein to bacteria, yeasts, or cultures of ...
... hosting a conference for researchers and clinicians on depression, ... Treatment Battlefeld and New Research," on Friday, November 1, ... Icahn School of Medicine at Mount Sinai, The Bonnie ... and 102nd Streets) in New York City. Recent meta-analyses ...
... electricity is hard to come by and scientific instruments are ... medical lab is rarely an option. Scientists are now reporting ... void with no electronics required. Their study on the extremely ... of time, appears in the ACS journal Analytical Chemistry ...
Cached Biology News:Biomolecules for the production line 2Biomolecules for the production line 3Towards a real understanding of depression 2